Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 137 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: SHIELD Clear all

Conditions: Parkinson Disease
Interventions: Karate Classes, Pre-Intervention Study Visit, Bimonthly Online Survey, 6-month Study Visit, 12-month Study Visit; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 30 Years to 90 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreas Cancer, Cancer
Interventions: CivaSheet; Device
Lead sponsor: CivaTech Oncology; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Breastfeeding
Interventions: FEEDBACK System; Device
Lead sponsor: Molex Ventures LLC; Industry
Eligibility: Up to 37 Weeks
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Radiation Protection
Interventions: Rampart IC System; Device
Lead sponsor: Baylor Research Institute; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndromes, Myelofibrosis, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Lymphoid Malignancies, Chronic Myelogenous Leukemia
Interventions: cyclophosphamide, fludarabine phosphate, total-body irradiation, cyclosporine, mycophenolate mofetil, umbilical cord blood transplantation, mesenchymal stem cell transplantation; Drug · Radiation · Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colo-rectal Cancer
Interventions: Guardant Shield; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 297 participants
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Congestive Heart Failure
Interventions: Azimilide 2HCl; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Choroidal Melanoma
Interventions: 1000CsK Silicon Oil Tamponade; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Infant, Newborn, Disease, Pain, Retinopathy of Prematurity, Eye Diseases
Interventions: phototherapy eye shield; Device
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: Up to 1 Year
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HIV, Substance Use Disorder (SUD)
Interventions: SHIELD 2.0; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Appetitive Behavior, Obesity
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 2
States / cities: Belmont, Massachusetts • Boston, Massachusetts

Conditions: Anterior Teeth
Interventions: Immediate implant placement and provisionalization; Procedure
Lead sponsor: Loma Linda University; Other
Eligibility: 21 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Loma Linda, California

Conditions: Hypoxia
Interventions: BORA Band SpO2 Validation Study; Device
Lead sponsor: Biosency; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere Biology Disorder, Bone Marrow Failure, Dyskeratosis Congenita, Telomere Biology Disorders
Interventions: Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY) (Plan 1), Fludarabine (FLU), Methylprednisolone (MP), Donor mobilized PBSC infusion, G-CSF, Cyclophosphamide (CY) (Plan 2), Rituximab, Busulfan, Alemtuzumab, Melphalan; Drug · Device
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: Up to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2029
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pharmacokinetics, Absorption; Chemicals
Interventions: Bemotrizinol (6%); Drug
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: West Bend, Wisconsin

Conditions: Meibomian Gland Dysfunction, Dry Eye Syndrome
Interventions: Sham Treatment, Pulsed Light Therapy; Device
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Facial Photodamage
Interventions: on-label facial injection; Other
Lead sponsor: Allergan; Industry
Eligibility: 30 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: San Diego, California • Houston, Texas

Conditions: Obsessive-Compulsive Disorder
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS), Sham; Device
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Intubation
Interventions: Barrier box; Other
Lead sponsor: The Guthrie Clinic; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Sayre, Pennsylvania

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Cognitive Change, Energy Metabolism, Sleep Disturbance
Interventions: MyTAP oral appliance plus mouth shield; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 55 Years to 85 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cannabis Use, Cannabis Use Disorder
Interventions: Magstim SuperRapid2, Sham rTMS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 15 Years to 21 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Phototoxic Response
Interventions: Sunscreen oil with 6% Bemotrizinol, Sunscreen oil vehicle, Dispersion of 6% BEMT in petrolatum, Petrolatum vehicle; Drug · Other
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: PTSD
Interventions: TMS 1 hz, Sham TMS; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 19 Years to 70 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: White River Junction, Vermont

Conditions: Impaired Thermoregulation
Interventions: Application of reflective heat shield to thermistor probe; Device
Lead sponsor: Maimonides Medical Center; Other
Eligibility: Up to 1 Week
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Brooklyn, New York

Search by objective public record fields.

Kick Out Parkinson's Disease 2

Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source

Pilot Study of the FEEDBACK System for Use With Infants in the Neonatal Intensive Care Unit at University of Virginia

Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial

Intra-Osseous Co-Transplant of UCB and hMSC

Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

Safety and Efficacy of Silicone Oil Tamponade for Surgical Attenuation of Radiation Damage in Choroidal Melanoma

Eye Shields for Infants After Dilated Exam

Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans

Maxillary Anterior Immediate Tooth Replacement With and Without Socket-shield

BiOSENCY BORA Band SpO2 Validation Study

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial

Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome

Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)

A Study Comparing Time to Intubate With and Without a Barrier Box

Brain Energy Metabolism and Sleep in Adults

Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder

Phototoxicity Potential of 6% Bemotrizinol

Transcranial Magnetic Stimulation to Improve Functioning in Veterans With PTSD

Study of the Need for Temperature Probe Covers for Newborn Babies on Radiant Warmers